SpaceX Secondary Sale and IPO Plans

P.M. Edition for Dec. 5. The streaming company won the fight for Warner Bros. in a deal that would shake up Hollywood. But first it has to win approval from the Trump administration, which is already scrutinizing the acquisition, as Wall Street Journal entertainment reporter Joe Flint explains. And a key vaccine panel at the CDC voted to drop a longtime recommendation that all newborns get a first dose of hepatitis B vaccine. WSJ reporter Sabrina Siddiqui covered the vote. Plus, the WSJ reports that SpaceX is kicking off a secondary stock sale that would value the company at $800 billion, ahead of a potential IPO for the rocket maker next year. Pierre Bienaimé hosts.

Sign up for the WSJ's free What's News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices